Molecular Formula | C24H24F2N8O2 |
Molar Mass | 494.5 |
Density | 1.45±0.1 g/cm3(Predicted) |
Boling Point | 716.0±70.0 °C(Predicted) |
Solubility | DMSO : 100 mg/mL (202.22 mM) |
pKa | 2?+-.0.10(Predicted) |
Storage Condition | -20°C |
In vitro study | Azd 0364 has high cellular activity on substrates directly downstream of the MAPK signaling pathway (as in BRAF. |
In vivo study | Azd 0364 has good oral pharmacokinetics in various species. In a xenograft model, AZD0364 inhibits phosphorylated p90RSK1 in a concentration-dependent manner in tumors. AZD0634 induces tumor regression in a KRAS-mutated NSCLC Calu 6 xenograft model in which AZD0634 can be safely and effectively administered in combination with selumetinib. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.022 ml | 10.111 ml | 20.222 ml |
5 mM | 0.404 ml | 2.022 ml | 4.044 ml |
10 mM | 0.202 ml | 1.011 ml | 2.022 ml |
5 mM | 0.04 ml | 0.202 ml | 0.404 ml |